Cibc Asset Management Inc Vir Biotechnology, Inc. Transaction History

Cibc Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$21.19 - $40.01 $110,315 - $208,292	-5,206 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$30.97 - $54.03 $216 - $378	-7 Reduced 0.13%	5,206 $218,000
Q3 2021 Nov 09, 2021	BUY	$34.9 - $54.54 $17,938 - $28,033	514 Added 10.94%	5,213 $227,000
Q1 2021 May 14, 2021	BUY	$26.34 - $83.07 $123,771 - $390,345	4,699 New	4,699 $241,000

220

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $1.06B
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.